Supplementary Table S7 from 131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study
Year: 2026
Type: supplementary-materials
Abstract: Summary of 18F-piflufolastat SUVmax in PSA50 Responders vs. Non-responders Enzalutamide
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165003196